Stephen Kantrow is a Respiratory physician affiliated with Louisiana State University. OpenAlex indexes 73 publications with 2,648 citations (h-index 20).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1514 Jefferson Hwy
New Orleans, LA 701212429
Telephone
504-842-4000Registry record last updated 2 Dec 2008.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Tanabe Pharma America, Inc.Program year20254 payments
- Amylyx Pharmaceuticals, Inc.Program year20241 payment
- MITSUBISHI TANABE PHARMA AMERICA, INC.Program year20243 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
48.2%Anticholinergic23.8%Glycopyrrolate100%Part D≥19 patientsCorticosteroid11.4%Breo Ellipta69%Fluticasone Propionate31%Part D<11 patients+ 3 more classes in this area
Blood & clotting
34.9%Factor Xa inhibitor34.9%Eliquis71%Xarelto29%Part D<11 patientsMetabolism & gastrointestinal
9.1%Corticosteroid9.1%Prednisone100%Part D≥13 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2004–2008 per NIH RePORTER. The latest:
- Ethanol & Infection on Mitochondrial Death Signaling
Lsu Health Sciences Center
FY2008$178,432P60AA009803 - Ethanol & Infection on Mitochondrial Death Signaling
Lsu Health Sciences Center
FY2007$172,328P60AA009803 - Ethanol & Infection on Mitochondrial Death Signaling
Lsu Health Sciences Center
FY2006$150,612P60AA009803
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The painful blue hurt: a rare limb- and life-threatening condition
The American Journal of the Medical Sciences
2024 - Discordance Between Invasive and NonInvasive Oxygen Saturation in Critically Ill COVID-19 Patients
Journal of Intensive Care Medicine
2023 - A WeChat-based smoking cessation intervention for Chinese smokers: A pilot study
Internet Interventions
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Gerardo Aristimuno, MD
Louisiana State University
Judd Shellito, MD
Louisiana State University
Jay Hollman, MD
Louisiana State University
Guy Orangio, MD
Louisiana State University
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Marshall University
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”